title: The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies.
authors: P C
authors: PC
authors: Huijgens
authors: A C
authors: AC
authors: van Loenen
authors: A M
authors: AM
authors: Simoons-Smit
authors: E
authors: E
authors: Prooy
authors: G J
authors: GJ
authors: Ossenkoppele
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002180:Candidiasis, Oral / Q000517:prevention & control*; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications; D008223:Lymphoma / Q000150:complications*; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications
chemical_list: D015725:Fluconazole